ENORLA Trademark

Trademark Overview

On Wednesday, August 9, 2017, a trademark application was filed for ENORLA with the United States Patent and Trademark Office. The USPTO has given the ENORLA trademark a serial number of 87562410. The federal status of this trademark filing is REGISTERED as of Tuesday, May 1, 2018. This trademark is owned by Glaxo Group Limited. The ENORLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral and immune system related diseases and disorders
enorla

General Information

Serial Number87562410
Word MarkENORLA
Filing DateWednesday, August 9, 2017
Status700 - REGISTERED
Status DateTuesday, May 1, 2018
Registration Number5457606
Registration DateTuesday, May 1, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral and immune system related diseases and disorders
Translation of Words in MarkThe wording "ENORLA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, May 1, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, November 8, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 7, 2018ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, May 1, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 10, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, December 29, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, December 26, 2017ASSIGNED TO LIE
Thursday, December 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 7, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, December 7, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 7, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, December 7, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 5, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, November 17, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 17, 2017LETTER OF SUSPENSION E-MAILED
Friday, November 17, 2017SUSPENSION LETTER WRITTEN
Friday, November 17, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, November 10, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, November 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 2, 2017ASSIGNED TO EXAMINER
Tuesday, August 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 12, 2017NEW APPLICATION ENTERED

Related Keywords

enorla pharmaceutical treatment diseases substances preparations related disorders system viral infectious